drugset / Trial / NCT00442546
Efficacy And Safety Of Pregabalin For Pain Following Total Knee Replacement
RandomizedParallel-groupDouble-blindTreatment
Summary
Pregabalin added to the standard of care with dosing starting preoperatively and continuing for up to 6 weeks post surgery will decrease the intensity of post-operative pain following total knee replacement.
Timeline
- Start
- 2007-05
- Primary completion
- 2008-12
- Completion
- 2008-12
Outcome
Missed primary endpoint
paper There were no statistically significant differences between the pregabalin and placebo groups with respect to the primary endpoint in any of the three trials. PMID 25565885 ↗
registry Pregabalin (300 mg) vs Placebo; p = 0.3619; Mean Difference (Final Values) -0.339 (95% CI -1.070 to 0.392) NCT00442546 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pregabalin | Small molecule | 150 mg | — |
| Subject | Pregabalin | Small molecule | 300 mg | — |